Beauty Farm Medical and Health Industry Inc. repurchased 38,000 ordinary shares on 6 May 2026 via on-market transactions, paying a total of HKD 0.75 million at prices ranging from HKD 19.58 to HKD 19.94 per share.

Following the transaction: • Issued shares (excluding treasury shares) decreased to 249.72 million. • Treasury shares increased to 1.87 million, representing 0.75 % of the 235.80 million shares outstanding when the current mandate was granted on 27 June 2025. • Total shares in issue remained unchanged at 251.59 million, as the repurchased shares are held in treasury rather than cancelled.

The shares were repurchased under the existing mandate, which authorises buybacks of up to 23.58 million shares. After this latest purchase, 1.87 million shares have been bought back under the mandate, leaving capacity for a further 21.71 million shares.

The moratorium on issuing new shares or selling treasury shares extends to 5 June 2026, in accordance with Hong Kong Stock Exchange rules.